Article

Circulating Proteome for Pulmonary Nodule Malignancy

2022-09-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> While lung cancer low-dose computed tomography (LDCT) screening is being rolled out in many regions around the world, differentiation of indeterminate pulmonary nodules between malignant and benign remains to a challenge for screening programs. We conducted one of the first systematic investigations of circulating protein markers for their ability to assess the risk of maligna...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f63199da-67b8-5f10-8f3b-92dd5dc3d45d
DOI: 10.1101/2022.09.24.22280288

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating Proteome for Pulmonary Nodule MalignancyDOI 10.1101/2022.09.24.22280288Read

A novel open access multimodal dataset of nodule imaging and circulating proteome from a lung cancer screening cohortSemantic proximity Read

Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging featuresSemantic proximity Read

Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assaySemantic proximity Read

Multi-Center Study of Resectable Lung Lesions by Ultra-Deep Sequencing of Targeted Genes in Plasma Cell-Free DNA to Assess Nodule Malignancy and Detect Lung CancersSemantic proximity Read

Genomics and the early diagnosis of lung cancerSemantic proximity Read

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancerSemantic proximity Read

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancerSemantic proximity Read

A novel proteomics-based plasma test for early detection of multiple cancers in the general populationSemantic proximity Read

Prognosis of Non–Small Cell Lung Cancer Patients by Detecting Circulating Cancer Cells in the Peripheral Blood with Multiple Marker GenesSemantic proximity Read

Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNASemantic proximity Read

A Peripheral Blood Transcriptomic Biomarker Panel Identified by Multiple Machine Learning Algorithms Enables Early Diagnosis and Prognosis Prediction in Lung CancerSemantic proximity Read

Prognostic and predictive biomarkers in non-small cell lung carcinoma.Semantic proximity Read